Renaissance Technologies - ENVVENO MEDICAL CORPORATION ownership

ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 23 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ENVVENO MEDICAL CORPORATION
ValueSharesWeighting
Q2 2023$36
-100.0%
11,745
-17.9%
0.00%
Q4 2021$94,00014,3000.00%
Other shareholders
ENVVENO MEDICAL CORPORATION shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 401,200$1,517,0002.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 219,180$829,0000.14%
Perceptive Advisors 781,615$2,954,0000.09%
ARTHUR M. COHEN & ASSOCIATES, LLC 24,000$91,0000.02%
UBS OCONNOR LLC 118,113$446,000,0000.01%
Sepio Capital, LP 10,800$41,0000.00%
WELLS FARGO & COMPANY/MN 2,049$8,0000.00%
NORTHERN TRUST CORP 13,906$53,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 81,723$308,0000.00%
View complete list of ENVVENO MEDICAL CORPORATION shareholders